Case Reports
doi: 10.1038/sj.bmt.1702099.
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect
Affiliations
- PMID: 10654025
- DOI: 10.1038/sj.bmt.1702099
Item in Clipboard
Case Reports
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect
Bone Marrow Transplant.
2000 Jan.
Abstract
Allogeneic hematopoietic stem cell transplantation should be considered as a therapeutic option for patients with generalized erythoderma or tumor stage MF. Indeed, the only curative option for MF may be an allogeneic transplant. Bone Marrow Transplantation (2000) 25, 111-113.
Similar articles
-
Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides.Bone Marrow Transplant. 2007 Aug;40(4):401-3. doi: 10.1038/sj.bmt.1705741. Epub 2007 Jun 25. Bone Marrow Transplant. 2007. PMID: 17589536 No abstract available.
-
Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.J Clin Oncol. 2005 Sep 1;23(25):6163-71. doi: 10.1200/JCO.2005.02.774. J Clin Oncol. 2005. PMID: 16135483
-
Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.Hematol Oncol. 2016 Mar;34(1):9-16. doi: 10.1002/hon.2162. Epub 2014 Oct 14. Hematol Oncol. 2016. PMID: 25312300
-
Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome.Dermatol Clin. 2015 Oct;33(4):807-18. doi: 10.1016/j.det.2015.05.014. Epub 2015 Jul 29. Dermatol Clin. 2015. PMID: 26433851 Review.
-
Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.Int Immunopharmacol. 2003 Aug;3(8):1121-43. doi: 10.1016/S1567-5769(03)00014-6. Int Immunopharmacol. 2003. PMID: 12860168 Review.
Cited by
-
Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.Cochrane Database Syst Rev. 2013 Aug 29;2013(8):CD008908. doi: 10.1002/14651858.CD008908.pub3. Cochrane Database Syst Rev. 2013. PMID: 23986525 Free PMC article.
-
Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis.Front Med (Lausanne). 2020 Jun 25;7:290. doi: 10.3389/fmed.2020.00290. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32714935 Free PMC article.
-
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant.Leuk Lymphoma. 2012 Jun;53(6):1124-1129. doi: 10.3109/10428194.2011.645818. Epub 2012 Jan 31. Leuk Lymphoma. 2012. PMID: 22136377 Free PMC article.
-
Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas.Cancers (Basel). 2020 Oct 3;12(10):2856. doi: 10.3390/cancers12102856. Cancers (Basel). 2020. PMID: 33023002 Free PMC article. Review.
-
Cutaneous T-cell lymphomas: a review of new discoveries and treatments.Curr Treat Options Oncol. 2012 Mar;13(1):102-21. doi: 10.1007/s11864-011-0179-8. Curr Treat Options Oncol. 2012. PMID: 22311555 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
